Hovione Drug For Further Processing
NDC Database

Hovione Drug For Further Processing

NDC Database

National Drug Code (NDC) records including drug products, NDC numbers, nonproprietary names, dosage forms, strengths, labelers and marketing information.

Drug for Further Processing
  • Total Records 24
  • Latest Marketing Date 2026-05-13
  • Data Source FDA
  • First Marketing Date 2016-01-28
All
48
View
Bulk Ingredient
24
View
Drug for Further Processing
24
View
Company Overview

Company

Hovione Drug For Further Processing

Country

Portugal

Social Profiles

LinkedIn
Company Snapshot

Hovione Drug For Further Processing

Sete Casas 2674 – 506 Loures, Portugal

Portugal

www.hovione.com/ hello@hovione.com View on Map
NDC Records ( 24 records )
2016
24 Feb
Drug for Further Processing NDC: 50909-1901

Nonproprietary Name

Sarolaner SDD

Dosage Form

POWDER

Strength

25 kg/100kg

Labeler

HOVIONE FARMACIENCIA SA

Marketing Category

DRUG FOR FURTHER PROCESSING

50909-1901

Substance

SAROLANER

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2016-02-24

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2024
01 Apr
Drug for Further Processing NDC: 50909-1907

Nonproprietary Name

ALXN2040/HPMCAS Solid Dispersion

Dosage Form

POWDER

Strength

0.8 kg/kg

Labeler

HOVIONE FARMACIENCIA SA

Marketing Category

DRUG FOR FURTHER PROCESSING

50909-1907

Substance

DANICOPAN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2024-04-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2024
20 Dec
Drug for Further Processing NDC: 50909-1908

Nonproprietary Name

Deutivacaftor spray dried dispersion

Dosage Form

POWDER

Strength

0.8 kg/kg

Labeler

HOVIONE FARMACIENCIA SA

Marketing Category

DRUG FOR FURTHER PROCESSING

50909-1908

Substance

DEUTIVACAFTOR

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2024-12-20

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2018
20 Jul
Drug for Further Processing NDC: 50909-1909

Nonproprietary Name

Ivosidenib solid dispersion intermediate

Dosage Form

POWDER

Strength

0.5 kg/kg

Labeler

HOVIONE FARMACIENCIA SA

Marketing Category

DRUG FOR FURTHER PROCESSING

50909-1909

Substance

IVOSIDENIB

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2018-07-20

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2025
30 Jan
Drug for Further Processing NDC: 50909-1910

Nonproprietary Name

Suzetrigine spay dried dispersion

Dosage Form

POWDER

Strength

0.25 kg/kg

Labeler

HOVIONE FARMACIENCIA SA

Marketing Category

DRUG FOR FURTHER PROCESSING

50909-1910

Substance

SUZETRIGINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2025-01-30

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2020
17 Apr
Drug for Further Processing NDC: 50909-1911

Nonproprietary Name

Tucatinib solid dispersion intermediate

Dosage Form

POWDER

Strength

0.5 kg/kg

Labeler

HOVIONE FARMACIENCIA SA

Marketing Category

DRUG FOR FURTHER PROCESSING

50909-1911

Substance

TUCATINIB

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2020-04-17

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2018
14 Feb
Drug for Further Processing NDC: 50909-1912

Nonproprietary Name

Apalutamide solid dispersion intermediate

Dosage Form

POWDER

Strength

0.25 kg/kg

Labeler

HOVIONE FARMACIENCIA SA

Marketing Category

DRUG FOR FURTHER PROCESSING

50909-1912

Substance

APALUTAMIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2018-02-14

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2025
25 Sep
Drug for Further Processing NDC: 50909-1913

Nonproprietary Name

Paltusotine.HCl SDD

Dosage Form

POWDER

Strength

15 kg/100kg

Labeler

Hovione FarmaCiencia SA

Marketing Category

DRUG FOR FURTHER PROCESSING

50909-1913

Substance

PALTUSOTINE HYDROCHLORIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2025-09-25

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2025
08 Aug
Drug for Further Processing NDC: 50909-1914

Nonproprietary Name

Zongertinib SDD intermediate

Dosage Form

POWDER

Strength

50 kg/100kg

Labeler

Hovione FarmaCiencia SA

Marketing Category

DRUG FOR FURTHER PROCESSING

50909-1914

Substance

ZONGERTINIB

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2025-08-08

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2023
20 Jul
Drug for Further Processing NDC: 50909-1915

Nonproprietary Name

QUIZARTINIB DIHYDROCHLORIDE SDD

Dosage Form

POWDER

Strength

12.73 kg/140kg

Labeler

HOVIONE FARMACIENCIA SA

Marketing Category

DRUG FOR FURTHER PROCESSING

50909-1915

Substance

QUIZARTINIB DIHYDROCHLORIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2023-07-20

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2016
28 Jan
Drug for Further Processing NDC: 50909-1916

Nonproprietary Name

Grazoprevir SD

Dosage Form

POWDER

Strength

30 kg/100kg

Labeler

HOVIONE FARMACIENCIA SA

Marketing Category

DRUG FOR FURTHER PROCESSING

50909-1916

Substance

GRAZOPREVIR

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2016-01-28

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2021
13 Aug
Drug for Further Processing NDC: 50909-1917

Nonproprietary Name

Belzutifan Spray Dried Intermediate

Dosage Form

POWDER

Strength

25 kg/100kg

Labeler

Hovione FarmaCiencia SA

Marketing Category

DRUG FOR FURTHER PROCESSING

50909-1917

Substance

BELZUTIFAN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2021-08-13

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2018
30 Aug
Drug for Further Processing NDC: 50909-1918

Nonproprietary Name

Doravirine Spray Dried

Dosage Form

POWDER

Strength

20 kg/100kg

Labeler

Hovione FarmaCiencia SA

Marketing Category

DRUG FOR FURTHER PROCESSING

50909-1918

Substance

DORAVIRINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2018-08-30

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2016
28 Jan
Drug for Further Processing NDC: 50909-1919

Nonproprietary Name

Elbasvir SD

Dosage Form

POWDER

Strength

20 kg/100kg

Labeler

HOVIONE FARMACIENCIA SA

Marketing Category

DRUG FOR FURTHER PROCESSING

50909-1919

Substance

ELBASVIR

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2016-01-28

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2019
28 Aug
Drug for Further Processing NDC: 50909-1920

Nonproprietary Name

Ledipasvir SDD 50% w/w

Dosage Form

POWDER

Strength

50 kg/100kg

Labeler

HOVIONE FARMACIENCIA SA

Marketing Category

DRUG FOR FURTHER PROCESSING

50909-1920

Substance

LEDIPASVIR

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2019-08-28

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2016
28 Jun
Drug for Further Processing NDC: 50909-1921

Nonproprietary Name

Velpatasvir SDD 50% w/w

Dosage Form

POWDER

Strength

50 kg/100kg

Labeler

Hovione FarmaCiencia SA

Marketing Category

DRUG FOR FURTHER PROCESSING

50909-1921

Substance

VELPATASVIR

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2016-06-28

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2017
18 Jul
Drug for Further Processing NDC: 50909-1922

Nonproprietary Name

Voxilaprevir SDD

Dosage Form

POWDER

Strength

5 kg/10kg

Labeler

Hovione FarmaCiencia SA

Marketing Category

DRUG FOR FURTHER PROCESSING

50909-1922

Substance

VOXILAPREVIR

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2017-07-18

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2023
27 Jan
Drug for Further Processing NDC: 50909-1923

Nonproprietary Name

Pirtobrutinib SDD

Dosage Form

POWDER

Strength

50 kg/100kg

Labeler

HOVIONE FARMACIENCIA SA

Marketing Category

DRUG FOR FURTHER PROCESSING

50909-1923

Substance

PIRTOBRUTINIB

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2023-01-27

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2024
11 Dec
Drug for Further Processing NDC: 50909-1924

Nonproprietary Name

Orforglipron SDD

Dosage Form

POWDER

Strength

30 kg/100kg

Labeler

HOVIONE FARMACIENCIA SA

Marketing Category

DRUG FOR FURTHER PROCESSING

50909-1924

Substance

ORFORGLIPRON CALCIUM

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2024-12-11

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2024
11 Dec
Drug for Further Processing NDC: 50909-1925

Nonproprietary Name

Orforglipron SDD

Dosage Form

POWDER

Strength

30 kg/100kg

Labeler

HOVIONE FARMACIENCIA SA

Marketing Category

DRUG FOR FURTHER PROCESSING

50909-1925

Substance

ORFORGLIPRON CALCIUM

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2024-12-11

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2025
30 Apr
Drug for Further Processing NDC: 50909-1926

Nonproprietary Name

DHE Spray Dried Dispersion

Dosage Form

POWDER

Strength

35.6 kg/100kg

Labeler

Hovione FarmaCiencia SA

Marketing Category

DRUG FOR FURTHER PROCESSING

50909-1926

Substance

DIHYDROERGOTAMINE MESYLATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2025-04-30

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2026
13 May
Drug for Further Processing NDC: 50909-1928

Nonproprietary Name

Sonrotoclax (BGB-11417) SDD

Dosage Form

POWDER

Strength

2 kg/10kg

Labeler

Hovione FarmaCiencia SA

Marketing Category

DRUG FOR FURTHER PROCESSING

50909-1928

Substance

SONROTOCLAX

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2026-05-13

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2024
20 Nov
Drug for Further Processing NDC: 50909-2001

Nonproprietary Name

Tobramycin 28mg Inhalation Powder Hard Capsule

Dosage Form

CAPSULE

Strength

28 mg/1

Labeler

HOVIONE FARMACIENCIA SA

Marketing Category

DRUG FOR FURTHER PROCESSING

50909-2001

Substance

TOBRAMYCIN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2024-11-20

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2025
16 Aug
Drug for Further Processing NDC: 50909-2002

Nonproprietary Name

Zongertinib Film-Coated Tablets, 60 mg

Dosage Form

TABLET, COATED

Strength

60 mg/1

Labeler

HOVIONE FARMACIENCIA SA

Marketing Category

DRUG FOR FURTHER PROCESSING

50909-2002

Substance

ZONGERTINIB

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2025-08-16

End Marketing Date

-

Listing Record Certified Through

2027-12-31

Related Databases
  • FDA Inspections
    20 View
  • EDQM CEP
    16 View
  • KDMF
    0 View
  • Japan DMF
    7 View
  • Eudra GMP
    0 View
  • NDC Database
    48 View
  • FDA Approved Drugs Database
    0 View
  • Drug Prices in Switzerland
    0 View
NDC Type Breakdown
24 total
  • Drug for Further Processing
Official Source

NDC data is based on publicly available National Drug Code information from the U.S. Food and Drug Administration (FDA).

Visit FDA NDC Directory
NDC Record Details Preview

Explore important National Drug Code information available in the records above.

NDC

50909-1901

Nonproprietary Name

Sarolaner SDD

Labeler

HOVIONE FARMACIENCIA SA

Dosage Form

POWDER

FDA NDC Data

National Drug Code information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized NDC records

NDC data is based on publicly available U.S. Food and Drug Administration (FDA) National Drug Code information.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.